The device, unlike the previous procedures that involved inherent risk of injury to organs lying beneath the abdominal wall such as the intestines, is applied with a negative pressure.

The negative pressure separates the abdominal wall from the underlying organs allowing for a safe and rapid entry of a veress needle for the introduction of inert gas and resulting insufflation of the abdomen followed by surgical intervention.

Life Care Medical Devices chief executive officer Glenn Foley said while surgical equipment advances and technique improvement have been an integral part of the development of the laparoscopic surgery market, the initial first step of access to the abdominal cavity has remained static.

"Our Keyhole Cup Laparoscopic Surgery Access Device gives the surgeon a method for rapid, consistent, and safe access to the abdominal region," Foley added.

"LCMD is currently in the process of distribution partner selection and plans initial commercialization in Q3 2013."